![Earn Perry](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Earn Perry
Fundador en Musli Thyropeutics Ltd. .
Cargos activos de Earn Perry
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Musli Thyropeutics Ltd. | Director/Miembro de la Junta | - | - |
Fundador | - | - | |
MyBiotics Pharma Ltd.
![]() MyBiotics Pharma Ltd. BiotechnologyHealth Technology MyBiotics Pharma Ltd. operates as a micro biome pharmaceutical company that develops live bacteria based drugs. It develops MyCrobe and SuperDonor technologies for growing specific bacterial communities on pre-selected particles for stable and resistant raw material and for multi bacterial products. The company was founded in and is headquartered in Ness Ziona, Israel. | Director/Miembro de la Junta | - | - |
Historial de carrera de Earn Perry
Antiguos cargos conocidos de Earn Perry.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Maruho Israel Innovation Fund
![]() Maruho Israel Innovation Fund Financial ConglomeratesFinance Maruho Israel Innovation Fund engages in investments in dermatology-related technologies, biotech, medical devices, digital health, and cosmetics. The company was founded by Junichi Hamada, Eran Perry, Doron Friedman, and Masanobu Ogawa in 2018 and is headquartered in Rehovot, Israel. | Fundador | 01/01/2018 | - |
Corporate Officer/Principal | 01/01/2018 | - | |
Upstream Bio, Inc.
![]() Upstream Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Upstream Bio, Inc. is a clinical-stage biopharmaceutical company based in Waltham, MA, USA. The American company's lead program, upb-101, is a monoclonal antibody that inhibits the TSLP receptor, a validated target that affects various immune cells involved in common and rare diseases. Upstream Bio is leveraging its diverse roots and substantial industry experience to develop therapies that ease the burden of inflammatory and allergic diseases on patients and their loved ones. The company was founded by Eran Perry and Earn Perry, and Samantha Truex has been the CEO since 2021. | Director/Miembro de la Junta | - | - |
Fundador | - | - | |
ICD Pharma Ltd. | Fundador | - | - |
Formación de Earn Perry.
The Trustees of Columbia University in The City of New York | Masters Business Admin |
Tel-Aviv University | Graduate Degree |
Estadísticas
Internacional
Israel | 6 |
Estados Unidos | 3 |
Operativa
Founder | 4 |
Director/Board Member | 3 |
Masters Business Admin | 1 |
Sectorial
Consumer Services | 3 |
Finance | 2 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 5 |
---|---|
ICD Pharma Ltd. | |
Musli Thyropeutics Ltd. | |
Maruho Israel Innovation Fund
![]() Maruho Israel Innovation Fund Financial ConglomeratesFinance Maruho Israel Innovation Fund engages in investments in dermatology-related technologies, biotech, medical devices, digital health, and cosmetics. The company was founded by Junichi Hamada, Eran Perry, Doron Friedman, and Masanobu Ogawa in 2018 and is headquartered in Rehovot, Israel. | Finance |
Upstream Bio, Inc.
![]() Upstream Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Upstream Bio, Inc. is a clinical-stage biopharmaceutical company based in Waltham, MA, USA. The American company's lead program, upb-101, is a monoclonal antibody that inhibits the TSLP receptor, a validated target that affects various immune cells involved in common and rare diseases. Upstream Bio is leveraging its diverse roots and substantial industry experience to develop therapies that ease the burden of inflammatory and allergic diseases on patients and their loved ones. The company was founded by Eran Perry and Earn Perry, and Samantha Truex has been the CEO since 2021. | Commercial Services |
MyBiotics Pharma Ltd.
![]() MyBiotics Pharma Ltd. BiotechnologyHealth Technology MyBiotics Pharma Ltd. operates as a micro biome pharmaceutical company that develops live bacteria based drugs. It develops MyCrobe and SuperDonor technologies for growing specific bacterial communities on pre-selected particles for stable and resistant raw material and for multi bacterial products. The company was founded in and is headquartered in Ness Ziona, Israel. | Health Technology |
- Bolsa de valores
- Insiders
- Earn Perry
- Experiencia